跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
T-51
首页
药物
T-51
T-51
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ANTI-CD22 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC CONSTRUCTS
EP 4188952 A4
申请人: NAT RES COUNCIL CANADA
优先权: 2020
CN
EP
US
WO
5 件公开
DIAMINE DERIVATIVES
EP 1405852 B9
申请人: DAIICHI SANKYO CO LTD
优先权: 2001
CN
EP
2 件公开
2-aryl-propionic acid and medicine composition containing same
CN 1612729 A
申请人: DOMPAY CO LTD
优先权: 2001
CN
2 件公开
Viral vectors having tissue tropism for T-lymphocytes, B- and mast cells
US 2003180258 A1
申请人: VAN ES HELMUTH HENDRIKUS GERAR
优先权: 2001
US
Optimized expression of HPV31 L1 in yeast
US 7276243 B2
申请人: MERCK & CO INC
优先权: 2005
US
Super-agonistic anti-CD-28 antibodies
EP 2497829 A1
申请人: THERAMAB LLC
优先权: 2005
EP
Use of at least a cationic cyanine derivative for use in hair dyeing, composition containg it process of treating keratinic fibres using the same composition, kit and use thereof
EP 1792605 A1
申请人: OREAL
优先权: 2005
EP
METHOD OF MAKING AN EXTRACT OF BIOLOGICALLY ACTIVE ADDITIVE
US 2007134347 A1
申请人: LISOVSKYL ANATOLY A
优先权: 2005
US
VISUALIZATION AND QUANTITATION OF CELLULAR CYTOTOXICITY USING CELL-PERMEABLE FLUOROGENIC PROTEASE SUBSTRATES AND CASPASE ACTIVITY INDICATOR MARKERS
US 2007184493 A1
申请人: ONCOIMMUNIN
优先权: 2007
US
特异结合高致病性禽流感病毒的抗体
CN 103483448 B
申请人: 厦门大学
优先权: 2012
CN
第 1 / 2 页
上一页
下一页
药物
反馈